Skip to content

Darwin Global Management, Ltd.

Follow

13F filer, CIK 1839209, ST. HELIER, Jersey

Darwin Global Management, Ltd. reported $3,991,376,206 across 5 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001892688-26-000178

Period
2026-09-30
Reported value
$3.99B
Holdings
5
Top 10 weight
100%
New
1
Sold out
1

Part of the filer group Darwin Global Management, Ltd.

  • Darwin Global Master Fund, Ltd.
  • Dr. Abhishek Trehan
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
GMABnew+17,899,876$639M
ABVXadded+400,000$39.6M
BLTEadded+19,913$3.38M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
INSMexited-6,431,163-$674M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001892688-26-000178, largest first. % of portfolio is the value over $3,991,376,206, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,211,018 shares; 2026Q2: 10,629,822 shares; 2026Q3: 10,629,822 shares 10,629,822$2.18B54.66%0Timeline
GMABGENMAB A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 17,899,876 shares 17,899,876$639M16%newTimeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,027,704 shares; 2026Q1: 3,057,412 shares; 2026Q2: 3,077,219 shares; 2026Q3: 3,097,132 shares 3,097,132$526M13.18%+19,913Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,164,501 shares; 2025Q4: 3,178,501 shares; 2026Q1: 3,468,657 shares; 2026Q2: 3,621,583 shares; 2026Q3: 4,021,583 shares 4,021,583$398M9.98%+400,000Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,797,300 shares; 2026Q2: 6,747,300 shares; 2026Q3: 6,747,300 shares 6,747,300$247M6.18%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INSMINSMED INC6,431,163$674Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001892688-26-000178 base2026-11-16